- McEwen Inc. has released a new Mineral Resource Estimate for its Tartan Mine Project in Manitoba, outlining 308,900 indicated and 302,700 inferred gold ounces (at a US$3,000/oz gold price) and progressing plans to restart the underground mine using existing 500 tpd permits.
- The company is pairing this resource update with a US$6,000,000 exploration budget, metallurgical test work including cyanide-free options, and assessment of a possible expansion to 1,000 tpd that could materially lift Tartan’s long-term production contribution.
- We’ll now examine how Tartan’s updated resource base and planned 500 tpd restart could influence McEwen’s broader investment narrative.
The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 22 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
McEwen Investment Narrative Recap
To own McEwen today, you largely need to believe in its plan to grow production through a mix of brownfield restarts and disciplined exploration. The updated Tartan resource adds scale and a clearer path to a 500 tpd restart, which supports the near term production growth story, but it does not remove the key execution risk around actually bringing new ounces online on time and on budget.
The Tartan update also fits neatly beside the recent Grey Fox resource upgrade, which outlined a larger, higher confidence gold inventory in another established mining camp. Together, these two projects help explain why some analysts see McEwen as building a pipeline of smaller, staged projects that could smooth future production and cash flow, rather than relying on any single large build to carry the growth narrative.
Yet behind the appeal of a Tartan restart, investors should be aware of the risk that refurbishing older infrastructure and managing costs could...
Read the full narrative on McEwen (it's free!)
McEwen's narrative projects $518.3 million revenue and $278.2 million earnings by 2029. This requires 37.9% yearly revenue growth and an earnings increase of about $243.8 million from $34.4 million today.
Uncover how McEwen's forecasts yield a $31.70 fair value, a 48% upside to its current price.
Exploring Other Perspectives
Before this Tartan news, the most optimistic analysts were assuming revenue could reach about US$466 million and earnings US$114 million by 2029, which is far more upbeat than consensus and leans heavily on timely new mines despite refurbishment and delay risks that may look different now.
Explore 6 other fair value estimates on McEwen - why the stock might be worth just $21.50!
Form Your Own Verdict
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your McEwen research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
- Our free McEwen research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate McEwen's overall financial health at a glance.
Ready To Venture Into Other Investment Styles?
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
- Capitalize on the AI infrastructure supercycle with our selection of the 36 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
- We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
- AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com